Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.

BACKGROUND: Immunotherapy is a promising method for the treatment of endometrial cancer (EC). We aimed to conduct a comprehensive bibliometric study of the top 100 most-cited publications on immunotherapy for EC and provide a reference for future research. METHODS: Global publications on immunotherapy for EC published from 1985 to the present in the Web of Science core database were retrieved. We focused on the study of the top 100 most-cited articles by extracting information such as year, country, journal, author, institution, literature, and keywords. Microsoft Excel, VOSviewer, and R were used to perform descriptive statistics and visual analyses. RESULTS: The top 100 most-cited articles were published between 2002 and 2022, including 70 original papers and 30 reviews. The total frequency of citations per article ranges from 15 to 287. Developed countries dominated these publications, with the United States contributing the most (50 articles). According to Bradford Law, 6 journals, including Gynecologic Oncology and the Journal of Clinical Oncology, are highly recommended. Santin A. D. from Yale University and Makker.V. from Memorial Sloan Kettering Cancer Center have made positive contributions. Among the top ten most-cited articles, 7 focused on clinical trials exploring the efficacy of immunotherapy drugs, of which 4 were lenvatinib combined with pembrolizumab for the treatment of advanced EC. The immune-microenvironment, immune antitumor mechanisms, immunomodulatory drugs, especially anti-pd-1/pd-l1 checkpoint inhibitors, and their clinical trials are the focus of current research. CONCLUSION: The attention of researchers from different countries to EC immunotherapy, especially immunosuppressants, has brought a breakthrough in this field. A large number of clinical trials have evaluated the efficacy and safety of immune agents, and immune combination therapy (especially targeted therapy) shows positive therapeutic promise. Immunodrug sensitivity and adverse events remain urgent issues. The key to promoting the development of EC immunotherapy is to select the best patients according to the molecular classification and immunophenotype such as tumor mutation load, MMR status, pd-l1 expression, tumor infiltrating immune cells to truly achieve accurate and personalized treatment. More new and influential EC immunotherapies, such as adoptive cell immunotherapy, still need to be explored in future clinical practice.

Designs of Tandem Catalysts and Cascade Catalytic Systems for CO2 Upgrading.

Upgrading CO2 into multi-carbon (C2+) compounds through the CO2 reduction reaction (CO2 RR) offers a practical approach to mitigate atmospheric CO2 while simultaneously producing high value chemicals. The reaction pathways for C2+ production involve multi-step proton-coupled electron transfer (PCET) and C-C coupling processes. By increasing the surface coverage of adsorbed protons (*Had ) and *CO intermediates, the reaction kinetics of PCET and C-C coupling can be accelerated, thereby promoting C2+ production. However, *Had and *CO are competitively adsorbed intermediates on monocomponent catalysts, making it difficult to break the linear scaling relationship between the adsorption energies of the *Had /*CO intermediate. Recently, tandem catalysts consisting of multicomponents have been developed to improve the surface coverage of *Had or *CO by enhancing water dissociation or CO2 -to-CO production on auxiliary sites. In this context, we provide a comprehensive overview of the design principles of tandem catalysts based on reaction pathways for C2+ products. Moreover, the development of cascade CO2 RR catalytic systems that integrate CO2 RR with downstream catalysis has expanded the range of potential CO2 upgrading products. Therefore, we also discuss recent advancements in cascade CO2 RR catalytic systems, highlighting the challenges and perspectives in these systems.

Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer.

Ovarian cancer is an aggressive tumor that remains to be the most lethal gynecological malignancy in women. Metabolic adaptation is an emerging hallmark of tumors. It is important to exploit metabolic vulnerabilities of tumors as promising strategies to develop more effective anti-tumor regimens. Tumor cells reprogram the metabolic pathways to meet the bioenergetic, biosynthetic, and mitigate oxidative stress required for tumor cell proliferation and survival. Oxidative phosphorylation has been found to be altered in ovarian cancer, and oxidative phosphorylation is proposed as a therapeutic target for management of ovarian cancer. Herein, we initially introduced the overview of oxidative phosphorylation in cancer. Furthermore, we discussed the role of oxidative phosphorylation and chemotherapeutic resistance of ovarian cancer. The role of oxidative phosphorylation in other components of tumor microenvironment of ovarian cancer has also been discussed.

Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Objective: To investigate the association between pretreatment prognostic nutritional index (PNI) and clinical survival outcomes for advanced-stage cancer patients treated with immune checkpoint inhibitors (ICIs). Methods: We conducted a comprehensive literature search to identify eligible studies concerning the relationship between pretreatment PNI and survival outcomes in advanced cancer patients treated with ICIs. Published data were extracted and pooled odds ratio (pOR) for objective response rate (ORR), disease control rate (DCR), and pooled hazard ratio (pHR) for overall survival (OS), progressive-free survival (PFS), along with 95% confidence intervals (95% CIs) were calculated. Results: Twelve studies with 1,359 participants were included in our study. A higher level of PNI indicated a greater ORR (pOR = 2.17, 95% CI = 1.52-3.10) and favorable DCR (pOR = 2.48, 95% CI = 1.87-3.29). Low PNI was associated with a shorter OS (pHR = 2.24, 95% CI = 1.57-3.20) and unfavorable PFS (pHR = 1.61, 95% CI = 1.37-1.88). Conclusion: Low PNI might be an effective biomarker of poor tumor response and adverse prognosis of advanced cancer patients with ICIs. Further studies are needed to verify the prognostic value of PNI in clinical practice.

Dynamic Activation of Adsorbed Intermediates via Axial Traction for the Promoted Electrochemical CO2 Reduction.

Regulating the local environment and structure of metal center coordinated by nitrogen ligands (M-N4 ) to accelerate overall reaction dynamics of the electrochemical CO2 reduction reaction (CO2 RR) has attracted extensive attention. Herein, we develop an axial traction strategy to optimize the electronic structure of the M-N4 moiety and construct atomically dispersed nickel sites coordinated with four nitrogen atoms and one axial oxygen atom, which are embedded within the carbon matrix (Ni-N4 -O/C). The Ni-N4 -O/C electrocatalyst exhibited excellent CO2 RR performance with a maximum CO Faradic efficiency (FE) close to 100 % at -0.9 V. The CO FE could be maintained above 90 % in a wide range of potential window from -0.5 to -1.1 V. The superior CO2 RR activity is due to the Ni-N4 -O active moiety composed of a Ni-N4 site with an additional oxygen atom that induces an axial traction effect.

Gas Diffusion Strategy for Inserting Atomic Iron Sites into Graphitized Carbon Supports for Unusually High-Efficient CO2 Electroreduction and High-Performance Zn-CO2 Batteries.

Emerging single-atom catalysts (SACs) hold great promise for CO2 electroreduction (CO2 ER), but the design of highly active and cost-efficient SACs is still challenging. Herein, a gas diffusion strategy, along with one-step thermal activation, for fabricating N-doped porous carbon polyhedrons with trace isolated Fe atoms (Fe1 NC) is developed. The optimized Fe1 NC/S1 -1000 with atomic Fe-N3 sites supported by N-doped graphitic carbons exhibits superior CO2 ER performance with the CO Faradaic efficiency up to 96% at -0.5 V, turnover frequency of 2225 h-1 , and outstanding stability, outperforming almost all previously reported SACs based on N-doped carbon supported nonprecious metals. The observed excellent CO2 ER performance is attributed to the greatly enhanced accessibility and intrinsic activity of active centers due to the increased electrochemical surface area through size modulation and the redistribution of doped N species by thermal activation. Experimental observations and theoretical calculations reveal that the Fe-N3 sites possess balanced adsorption energies of *COOH and *CO intermediates, facilitating CO formation. A universal gas diffusion strategy is used to exclusively yield a series of dimension-controlled carbon-supported SACs with single Fe atoms while a rechargeable Zn-CO2 battery with Fe1 NC/S1 -1000 as cathode is developed to deliver a maximal power density of 0.6 mW cm-2 .

Nanoconfined Tin Oxide within N-Doped Nanocarbon Supported on Electrochemically Exfoliated Graphene for Efficient Electroreduction of CO2 to Formate and C1 Products.

Developing low-cost and effective electrocatalysts for electrochemical reduction of CO2 (CO2ER) is critical to CO2 conversion and utilization. Herein, we report a novel two-dimensional (2D) confined electrocatalyst composed of core-shell structured tin oxide nanoparticles (NPs) encapsulated into N-doped carbon (NC) supported on electrochemically exfoliated graphene (SnO2⊃NC@EEG) prepared by in situ carbonization of a 2-methylimidazole/SnO2 complex@poly(vinyl pyrrolidone) (PVP)-modified EEG precursor. The SnO2 NPs with an average size of ∼10 nm are confined in the NC shells with a thickness of 0.7 nm derived from 2-methylimidazole. The resulting 2D confined electrocatalyst significantly enhances the CO2ER performance with a small onset potential of -0.45 V, and high Faradic efficiencies of 81.2 and 93.2% for HCOO- and C1 products at -1.2 V, respectively, which is far superior to other reported SnO2/carbon-based CO2ER hybrids. The superb CO2ER catalytic activity of the SnO2⊃NC@EEG has resulted from the positive effect of N dopants and a strong confinement effect, which significantly expedites the CO2 adsorption associated with charge transfer from the NC to SnO2 NPs during CO2ER electrocatalysis.

A Universal Principle to Accurately Synthesize Atomically Dispersed Metal-N4 Sites for CO2 Electroreduction.

Atomically dispersed metal-nitrogen sites-anchored carbon materials have been developed as effective catalysts for CO2 electroreduction (CO2ER), but they still suffer from the imprecisely control of type and coordination number of N atoms bonded with central metal. Herein, we develop a family of single metal atom bonded by N atoms anchored on carbons (SAs-M-N-C, M = Fe, Co, Ni, Cu) for CO2ER, which composed of accurate pyrrole-type M-N4 structures with isolated metal atom coordinated by four pyrrolic N atoms. Benefitting from atomically coordinated environment and specific selectivity of M-N4 centers, SAs-Ni-N-C exhibits superior CO2ER performance with onset potential of - 0.3 V, CO Faradaic efficiency (F.E.) of 98.5% at - 0.7 V, along with low Tafel slope of 115 mV dec-1 and superior stability of 50 h, exceeding all the previously reported M-N-C electrocatalysts for CO2-to-CO conversion. Experimental results manifest that the different intrinsic activities of M-N4 structures in SAs-M-N-C result in the corresponding sequence of Ni > Fe > Cu > Co for CO2ER performance. An integrated Zn-CO2 battery with Zn foil and SAs-Ni-N-C is constructed to simultaneously achieve CO2-to-CO conversion and electric energy output, which delivers a peak power density of 1.4 mW cm-2 and maximum CO F.E. of 93.3%.